Anthony Letai Has Been Appointed the 18th Director of the National Cancer Institute

Anthony Letai

Eric Small: Excited to Share the Next Installment in My Science Matters Series

Eric Small

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Sek Kathiresan: Thrilled to Join Eli Lilly and Co. as Senior Vice President

Sek Kathiresan

Transforming Cancer Care with CancerX Accelerator 2026 - CancerX

CancerX

Giuseppe Curigliano: The ROME Trial - A National Effort to Bring Genomics to the Heart of Cancer Care in Italy

Giuseppe Curigliano

Paving the Way for a Smoke-Free Generation by 2040 - European Cancer Organisation

European Cancer Organisation

Svetlana Nikic: Navigating CNEDiMTS, RIHN 2.0, and PECT in France’s Precision Oncology Reimbursement

Svetlana Nikic

OncoCalendar

« All Events

  • This event has passed.

LATAM Course II: Immunotherapy in Lung Cancer by IASLC

Dec 19, 2024 • 4:00 PM - 5:00 PM
LATAM Course II: Immunotherapy in Lung Cancer by IASLC

LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19, 2024.

This exclusive Live Course on the latest updates in lung cancer treatment, specifically focusing on immunotherapy, offers a deep dive into the transformative impact of immunotherapy on lung cancer care in Latin America (LATAM). In Series II of the course, leading thoracic oncology experts from the region will lead discussions on pivotal aspects of immunotherapy in lung cancer treatment.

Key topics will include the integration of biomarkers for immunotherapy, which play a critical role in selecting the right patients and optimizing treatment efficacy. Experts will also explore best management strategies for advanced lung cancer, addressing the evolving landscape of treatment options, and discuss specific challenges faced in clinical practice, such as the management of pneumonitis, a common side effect associated with immunotherapy.

The Link for Registration.

See the Speakers and Series II LATAM Team Below:

LATAM Course II: Immunotherapy in Lung Cancer by IASLC

Details

Date:
Dec 19, 2024
Time:
4:00 PM - 5:00 PM
Website:
https://www.iaslc.org/node/35047

Organizer

The International Association for the Study of Lung Cancer (IASLC)
Phone
1-855-464-2752
Email
info@iaslc.org